Skip to main content
Clinical Trials/NCT04193969
NCT04193969
Completed
Not Applicable

The Association Between Changes in Radicular Pain and Pain Modulation Among Patients With Lumbar Radiculopathy: A Pilot Study.

Spine Centre of Southern Denmark1 site in 1 country80 target enrollmentNovember 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Back Pain
Sponsor
Spine Centre of Southern Denmark
Enrollment
80
Locations
1
Primary Endpoint
Conditioned pain modulation (change in pain sensitivity during a competing pain stimulus) measured with computer-controlled cuff algometry
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The objectives of this study are: 1)To investigate the difference in pain modulatory mechanisms using quantitative sensory testing (QST) between healthy controls and patients with radicular leg pain due to nerve root compression. 2) To investigate the association between changes in radiating leg pain and pain modulation among the patient group.

Detailed Description

Few studies have investigated pain modulatory mechanisms using QST in patients with lumbar radiculopathy due to nerve root compression. Knowledge about the association between changes in the experience of pain and changes measures of pain modulation is to our knowledge limited. The results could potentially contribute to knowledge about mechanisms involved in lumbar radiculopathy and facilitate future studies. The hypotheses of the study are: 1) Measures of pain modulation will be less efficient among patients with lumbar radiculopathy showing reduced pain inhibition and facilitated temporal summation compared to healthy controls. 2) Improvements in pain modulation will be associated with improvements in clinical pain outcomes

Registry
clinicaltrials.gov
Start Date
November 1, 2019
End Date
September 21, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Spine Centre of Southern Denmark
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient group
  • Radiating leg pain due to nerve root compression verified by MRI
  • Clinical findings in accordance with MRI findings
  • Average leg pain ≥ 3/10 on a numeric pain rating scale Controls
  • No current or previous history of ongoing musculoskeletal pain

Exclusion Criteria

  • Applies for both groups.
  • Other specific medical conditions e.g. rheumatologic disease, diabetes or vascular diseases.
  • Pregnancy

Outcomes

Primary Outcomes

Conditioned pain modulation (change in pain sensitivity during a competing pain stimulus) measured with computer-controlled cuff algometry

Time Frame: At baseline and at discharge from treatment throughout study completion, an average of 6 months. The timeframe between the baseline test and follow up test for controls will be matched the patient group.

Change in pain intensity between baseline and follow-up. Cuff is placed on the lower leg. In patients the non-painful leg is used, in healthy controls, half of the participants will be tested on the left leg and half on the right leg. 10 painful stimuli are performed with a one-second interval in between. After each stimulus, the participant rates the pain intensities using an electronic VAS ( 0=No pain, 10=worst pain imaginable pain). The increase in pain intensity is defined as temporal summation.

Cuff sensitivity, measured with computer-controlled cuff algometry

Time Frame: At baseline and at discharge from treatment throughout study completion, an average of 6 months. The timeframe between the baseline test and follow up test for controls will be matched the patient group.

Change in pain sensitivity between baseline and follow-up. Cuff is placed around the lower leg and on the upper arm and gradually inflated (1kPa/sec) on each location separately. In patients, the cuff is placed on the non-painful leg and left upper arm, in healthy controls, half of the participants the cuff is placed on the left leg and half on the right leg, while the other cuff is placed on the left upper arm. First, the pressure needed to evoke an onset of pain (pain detection threshold, PDT), the pressure at pain intensity VAS 6 (Measured on an electronic visual analogue scale: 0=No pain, 10=worst pain imaginable pain) and pain tolerance threshold (PTT) is assessed on the lower leg. Secondly, the PDT and the PTT is assessed on the left upper arm.

Temporal summation of pain (increase in pain during repeated pain stimuli at same intensity) measured with computer-controlled cuff algometry

Time Frame: At baseline and at discharge from treatment throughout study completion, an average of 6 months. The timeframe between the baseline test and follow up test for controls will be matched the patient group.

Change in pain intensity between baseline and follow-up. Cuff is placed on the lower leg. In patients the non-painful leg is used, in healthy controls, half of the participants will be tested on the left leg and half on the right leg. 10 painful stimuli are performed with a one-second interval in between. After each stimulus, the participant rates the pain intensities using an electronic VAS ( 0=No pain, 10=worst pain imaginable pain). The increase in pain intensity is defined as temporal summation.

Secondary Outcomes

  • Leg pain (measured on the low back pain rating scale)(At baseline and at discharge from treatment throughout study completion, an average of 6 months.)
  • Back pain and leg pain (measured on the low back pain rating scale)(At baseline and at discharge from treatment throughout study completion, an average of 6 months.)
  • Disability (Measured on the Oswestry Disability index)(At baseline and at discharge from treatment throughout study completion, an average of 6 months.)

Study Sites (1)

Loading locations...

Similar Trials